Matches 1 - 45 out of 45
Match Document Document Title
7381414 Mycoplasma vaccine, method of making, and application thereof  
The present invention provides a mycoplasma vaccine, its preparation and application thereof. The foregoing mycoplasma vaccine comprises inactivated Mycoplasma hyorhinis ATIT-7 only or the...
7217420 Mycoplasma gallisepticum formulation  
The present invention provides a protective formulation that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes. The formulation comprises a protective amount...
RE39494 Inactivated mycoplasma hyopneumoniae and uses therefor  
The invention relates to a method for making an inactivated vaccine of Mycoplasma hyopneumoniae by inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of...
7169394 Mycoplasma hyopneumoniae bacterin vaccine  
The invention provides an improved Mycoplasma hyopneumoniae bacterin vaccine composition, which advantageously provides immunity from infection after a single administration. The composition...
7056492 Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle  
The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma bovis ( M. bovis ) by administering to the animal an...
7018638 Mycoplasma hyopneumoniae bacterin vaccine  
The invention provides an improved Mycoplasma hyopneumoniae bacterin vaccine composition, which advantageously provides immunity from infection after a single administration. The composition...
6936707 Modified DNA molecule, recombinant containing the same, and uses thereof  
There is provided a DNA molecule derived from a prokaryotic cell in which at least one of the DNA regions encoding NXB (N is asparagine, X is any amino acid other than proline, and B is serine or...
6846477 One dose vaccination with Mycoplasma hyopneumoniae  
The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae ( M. hyo ) by administering to the animal at...
6720160 Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals  
The present invention involves a method and an immuno-analytical device for the rapid and simultaneous detection of multiple micro-organisms in the biological fluids from milk-producing animals...
6664099 Method for the preservation of viruses and mycoplasma  
A biologically-active material comprising a live virus or mycoplasma is preserved by a method of desiccation, without lyophilisation, in a matrix of glassy trehalose having a residual moisture...
6585981 Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae  
The present invention provides a live temperature-sensitive vaccine for Mycoplasma hyopneumoniae . The present invention also provides methods of vaccinating a swine against colonization or...
6548069 Multivalent Mycoplasma bacterin  
The present invention provides a bacterin comprising at least two virulent Mycoplasma bovis isolates of differing biotypes, in an amount sufficient to immunize a calf or cow against infection by ...
6537552 Vaccine adjuvant  
The invention features fusion agents such as fusion proteins that are useful for the treatment of and prevention from diseases that are susceptible to the effects of cellular (Th1 type) immune...
6432714 Prophylactic and therapeutic method  
Antigenic and/or immunoregulatory material derived from Mycobacterium vaccae is useful in the prophylaxis or therapy of AIDS with or without associated tuberculosis.
6379676 Enhancing immune response in animals  
A method for improving the immune response of an animal to a vaccine, comprising: feeding an animal a diet of contamination-resistant feed, and treating said animal with an anti-viral or...
6376203 Glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasma  
Mouse is immunized with an antigen of a lipid fraction originating from Mycoplasma fermentans . Its spleen cells are fused with mouse myeloma cells to prepare hybridomas. A hybridoma is selected,...
6217883 Porcine circovirus and paravovirus vaccine  
The invention relates to antigenic preparations and vaccines directed against the porcine multisystemic wasting syndrome (PMWS), comprising at least one porcine circovirus antigen, preferably type...
6204003 Methods for the diagnosis of feline infectious anemia  
The claimed invention is a method for determining whether a mammal is infected with Haemobartonella felis or for inducing an immune response against Haemobartonella felis using a polypeptide...
6162435 Recombinant mycoplasma hyopneumoniae vaccine  
A Mycoplasma hyopneumoniae protein prepared by recombinant DNA or synthetic means, DNA sequences coding for the protein, an expression vector and transformed host containing the DNA sequences, a...
6162433 Non antibiotic selectable markers for live vaccines  
The invention relates to DNA constructs encoding a safe, selectable marker, other than an antibiotic resistance marker, vectors and/or cells including said constructs; and vaccines based on said...
6113916 Method of enhancing cell mediated immune responses  
This intention provides a method for enhancing a cell mediates immune response to Mycoplasma hypneumoniae in a newborn swine which involves administering a vaccine containing an effective amount of...
6001348 Non-virulent Mycoplasma synoviae and vaccine thereof  
The present invention provides NAD-independent Mycoplasma synoviae of strain MS1. The invention also refers to microbiological cultures comprising Mycoplasma synoviae of this strain. Next to this,...
5989553 Expression library immunization  
A general method for vaccinating against any pathogen is presented. The method utilizes expression library immunization, where an animal is inoculated with an expression library constructed from...
5985264 IL-12 Stimulation of Neonatal immunity  
The present invention relates to a method of inducing a Th1-like response against a pathogen in a neonatal host, which comprises administering to the neonatal host an effective amount of IL-12 and...
5968525 Inactivated Mycolplasma hyopneumoniae and uses therefor  
The invention relates to a method for making an inactivated vaccine of Mycoplasma hyopneumoniae by inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of...
5871742 Recombinant Avipox virus encoding polypeptide of mycoplasma gallisepticum, and utilized a live vaccine  
A polypeptide exhibiting the antigenicity of Mycoplasma gallisepticum, a fused polypeptide comprising the above polypeptide and, connected to the N-terminus thereof, a signal membrane anchor of a...
5788962 DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures  
Mycoplasma hyopneumoniae P65 surface antigens prepared by recombinant DNA or synthetic methods, protein antigens encoded by P65 gene, an expression vector and transformed host containing the...
5766594 Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same  
Antigen proteins of Mycoplasma gallisepticum, genes encoding the antigen protein, recombinant vectors integrated with the gene and hosts transformed with the vector are provided. Diagnostics and...
5565205 Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof  
This invention provides a bacterin comprising a virulent Mycoplasma hyopneumoniae isolate, inactivated with binary ethyleneimine, in an amount effective to immunize a swine against infection by...
5498527 Phosphorylcholine-containing glyceroglycolipid  
The invention is directed to the compound 1'-[2,3-Bis(hexadecanoyloxy)propyl]-d-glycopyranos-6'-yl-2"- (trimethylammo nium)ethylphosphate which is a phosphorylcholine-containing glyceroglycolipid...
5489430 Poultry mycoplasma antigen, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same  
A highly effective vaccine for Mycoplasma gallisepticum infection utilizing a substantially pure protein capable of reacting with Mycoplasma gallisepticum immunized serum or Mycoplasma...
5459048 DNA encoding 85kd polypeptide useful in diagnosis of Mycoplasma infections in animals  
A class of polypeptides useful in an in vitro diagnosis of Mycoplasma infection in animals is disclosed. These polypeptides are also capable of inducing an immune response in swine which were...
5338543 Thimerosal inactivated mycoplasma hyopneumoniae vaccine  
The invention relates to a method for making an inactivated vaccine of Mycoplasma hyopneumoniae by inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of...
5252328 Mycoplasma hyopneumoniae antigen and uses therefor  
A composition for protecting swine against mycoplasmal pneumonia caused by M. hyopneumoniae which includes at least one protein which is an M. hyopneumoniae antigen. The M. hyopneumoniae antigen is...
5242823 Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen  
Regression associated antigens (RAAs) are identified in material from neoplastic cells by their immunological reactivity with regression associated antibodies from the serum of patients diagnosed...
5240706 Intranasal administration of Mycoplasma hyopneumoniae antigen  
A method for protecting an animal, in particular swine, against mycoplasma pneumonia by administering intranasally to the animal a vaccine containing one or more proteins which elicits an antibody...
5182109 Vaccine preparation comprising a bacterial toxin adjuvant  
A vaccine preparation comprising in combination a vaccine and a toxin or subunit thereof as an effective component. The toxin is preferably a bacterial toxin, e.g. cholera toxin, staphylococcal...
5064647 Mycoplasma vaccine  
The present invention is concerned with a novel Mycoplasma vaccine which is avirulent for chickens and is not pathogenic for turkeys. In particular such vaccine contains the Mycoplasma strain...
5004607 Method of immunizing poultry  
A method of immunizing chickens in which a vaccine preparation containing both an inactivated mycoplasma and an adjuvant which stimulates the mucosal immune system is administered to chickens...
4985243 Composition and method for protecting against diseases caused by microorganisms  
A vaccine for protecting against a disease caused by a microorganism which does not synthesize nucleic acid precursors such as a Micoplasma organism, which contains nuclease and/or a nuclease...
4039657 Separating antigen from residual common sensitizing protein  
Sensitizing plasma protein is dissociated from antigen-plasma protein complex by agitating at low temperature under controlled pH.
3917819 Method for preventing respiratory mycoplasmosis of livestocks  
Respiratory mycoplasmosis of livestocks such as fowl chronic respiratory disease, swine enzootic pneumonia and contagious pleuropneumonia of goats are effectively immunised by spraying or injecting...
3627874 VACCINE PREPARATION  
A nonanaphylactic PPLO vaccine is prepared by propagation of the organism at controlled pH in a medium containing fractionated calf serum. The fractionated calf serum is prepared by precipitation...
3534136 M.G. INOCULUM FOR POULTRY  
3485721 PROCESS FOR GROWING MYCOPLASMA PNEUMONIAL ORGANISMS  
Matches 1 - 45 out of 45